Tagesschau about PARK INNOVAARE
Together with leadXpro, SRF camera team visits the SwissFEL accelerator On the occasion of the official launch of Switzerland Innovation Park in Bern...
More details More detailsleadXpro one year in operation: all goals achieved, and even more!
Today, leadXpro AG, one of PARK INNOVAARE’s residents, celebrates its first anniversary and breathtaking development as a company in its first year of...
More detailsNEW COLLABORATION ON A GPCR LEAD DISCOVERY PROJECT
Axxam SpA and leadXpro AG announce this week a collaboration for the discovery of novel small molecule lead compounds for a newly discovered GPCR involved...
More detailsleadXpro about possibilities of new XFEL for applied research
Biotech startup leadXpro AG, at home at PARK INNOVAARE, applies serial crystallography among many other methods for structure-based drug design. It recently...
More detailsLEADXPRO SCIENTISTS CHART THE FUTURE OF STRUCTURE BASED DRUG DISCOVERY
In a series of scientific publications leadXpro AG scientists explore the utility of cutting-edge X-ray technologies for the discovery of new therapeutics. Medicines...
More detailsStructure-based drug discovery drives the development of novel treatment options
Drug development is a long and unpredictable process that requires high levels of investment, endurance and state-of-the-art technology. Basic research...
More detailsShaping the future of modern drug discovery
Video interview with Professor Dr. Gebhard Schertler Pharmaceutical and biotechnological industries often depend on the information acquired through...
More detailsThe value of the absolute structure
The exact knowledge and understanding of a molecule’s structure underpin all the substantial progress in chemical, agrarian and pharmaceutical research....
More detailsUnprecedented speed and success rate with delivering ligand-bound GPCR structures
Modern drug discovery greatly benefits from knowledge of how a drug interacts with its molecular drug target. Membrane protein drug targets represent a...
More detailsleadXpro “unlocks” new targets for structure-based drug discovery
One of the most promising groups of drug targets is that of integral membrane proteins. They are responsible for communicating signals from the outside...
More details